Sort by 'likes'
Early Treatment of Myeloma with Dr. Irene Ghobrial
Stopping myeloma before it even gets started! Lot of work is being done in this preventative approach and Dr. Irene Ghobrial of Dana Farber Cancer Institute will be talking to us about the new strategies to help MGUS and smoldering…
Unraveling Castleman Disease
Dr. David Fajgenbaum was diagnosed with a rare disorder that killed 35% of patients within five years of diagnosis. Dr. Fajgenbaum realised that he would have to lead the charge against his rare condition and we are talking to this…
Fighting Polycystic Ovary Syndrome (PCOS) – New Developments in Symptoms Management & Treatment
PCOS is a little understood life changing syndrome. What we know about PCOS are the disturbing symptoms it creates in our bodies, but we only know the tip of the iceberg when it comes to reasons behind why these symptoms…
Melflufen for Myeloma: A Deep Dive
The FDA recently granted priority review to a new drug application for melflufen (INN melphalan flufenamide), in combination with dexamethasone. Melflufen is intended for use as a first choice for patients with multiple myeloma whose disease is refractory to at…
Evolving Treatment Landscape of Psoriasis. More than Skin Deep.
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The impact of this autoimmune skin condition goes much deeper with raised cardiovascular risk, inflammatory arthritis and other…